Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $8,501 - $13,995
-84 Reduced 0.92%
9,092 $1.08 Million
Q1 2024

May 06, 2024

BUY
$85.37 - $115.44 $498,390 - $673,938
5,838 Added 174.9%
9,176 $977,000
Q4 2023

Feb 07, 2024

SELL
$69.51 - $104.43 $21,270 - $31,955
-306 Reduced 8.4%
3,338 $331,000
Q3 2023

Oct 30, 2023

SELL
$96.41 - $126.61 $276,793 - $363,497
-2,871 Reduced 44.07%
3,644 $376,000
Q2 2023

Aug 08, 2023

BUY
$118.5 - $160.53 $284,755 - $385,753
2,403 Added 58.44%
6,515 $791,000
Q1 2023

May 11, 2023

BUY
$135.66 - $197.02 $557,833 - $810,146
4,112 New
4,112 $631,000
Q1 2022

May 11, 2022

SELL
$126.46 - $235.05 $2,908 - $5,406
-23 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$225.82 - $368.51 $910,506 - $1.49 Million
-4,032 Reduced 99.43%
23 $6,000
Q3 2021

Nov 03, 2021

SELL
$221.9 - $484.47 $211,248 - $461,215
-952 Reduced 19.01%
4,055 $1.56 Million
Q2 2021

Aug 04, 2021

BUY
$129.91 - $234.98 $12,991 - $23,498
100 Added 2.04%
5,007 $1.18 Million
Q1 2021

May 11, 2021

BUY
$109.18 - $185.98 $15,940 - $27,153
146 Added 3.07%
4,907 $643,000
Q4 2020

Feb 09, 2021

SELL
$65.74 - $169.86 $693,031 - $1.79 Million
-10,542 Reduced 68.89%
4,761 $498,000
Q3 2020

Dec 10, 2020

SELL
$54.34 - $94.85 $760 - $1,327
-14 Reduced 0.09%
15,303 $1.08 Million
Q2 2020

Aug 11, 2020

SELL
$29.67 - $80.0 $244,124 - $658,240
-8,228 Reduced 34.95%
15,317 $983,000
Q1 2020

May 08, 2020

BUY
$17.78 - $31.58 $418,630 - $743,551
23,545 New
23,545 $705,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Nvwm, LLC Portfolio

Follow Nvwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nvwm, LLC with notifications on news.